BioAv Cancer Research Results
BioAv, bioavailability: Click to Expand ⟱
| Source: |
| Type: measurement |
Bioavailability (usually in %) absorbed by the body.
|
Park, Parkinson's Disease (PD): Click to Expand ⟱
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms, and is due to the degeneration of dopaminergic neurons. It is multifactorial, caused by genetic and environmental factors and currently has no definitive cure.
-CoQ10 deficiency was observed at a higher frequency in Parkinson's disease
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*neuroP↑, *antiOx↑, *Inflam↓, *BioAv↝, *BioAv↑, *Half-Life↝, *TLR4↓, *NF-kB↓, *iNOS↓, *COX2↓, *TNF-α↓, *12LOX↓, *NLRP3↓, *ROS↓, *IL1β↓, *IL6↓, *GSK‐3β↓, *NRF2↑, *BBB↑, *SOD↑, *GPx↑, *MDA↓,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
- |
Review, |
Arthritis, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
cardioP↑, Inflam↓, cognitive↑, *hepatoP↑, *ROS?, *SOD↑, *GSH↑, *MMP↑, *GutMicro↑, ChemoSen↑, *TNF-α↓, *IL10↑, *IL6↓, *eff↑, *ROS↓, *COX2↓, *NF-kB↓, *STAT3↓, *PGE2↓, *MPO↓, *IL1β↓, *MMP2↓, *MMP9↓, *β-Amyloid↓, *neuroP↑, *Dose↝, *BioAv↝, *BioAv↝, *BBB↑, *BDNF↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*memory↑, *cognitive↑, *ROS↓, *Inflam↓, *motorD↑, *toxicity↓, *TRPV3↑, *other↓, *antiOx↑, *LDL↓, *COX2↓, *PPARα↑, *NO↓, *AChE↓, *eff↑, *SOD↑, *Catalase↑, *neuroP↑, *BioAv↝, *BBB↑, *BioAv↑,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*antiOx↑, *ROS↓, *neuroP↑, *NO↑, BioAv↝, *BBB↑, *toxicity↑, *eff↑, *GSH↑, *SOD↑, *Aβ↓, *12LOX↓, *COX2↓, *Catalase↑, *Inflam↓, *TNF-α↓, *IL6↑, *lipid-P↓, NF-kB↓, IL1β↓, NRF2↑, HO-1↑, GSTs↑, cognitive↑, *BDNF↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
MS, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*Inflam↓, *antiOx↑, *neuroP↑, *BioAv↝, *BBB↑, *TNF-α↓, *IL1β↓, *IL6↓, *IL8↓, *IL33↓, *NF-kB↓, *BACE↓, *ROS↓, *SOD↑, *HO-1↑, *NRF2↑, *Casp3↓, *Casp9↑, *Bax:Bcl2↓, *UPR↑, *GRP78/BiP↑, *Aβ↓, *GSK‐3β↓, *tau↓, *CREB↑, *ATP↑, *cognitive↑, *BloodF↑, *BDNF↑, *TrkB↑, *memory↑, *PPARγ↑, *eff↑,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*antiOx↑, *ROS↓, *BioAv↝, *Half-Life↑, *BioAv↓, *BioAv↑, *cardioP↑, *neuroP↑, *H2O2↓, *VitC↑, *VitE↑, *GPx↑, *GSH↑, *MPO↓, *GSTs↓, *SOD↑, *NF-kB↓, *IL1β↓, *IL6↓, *IL10↑, *MAPK↓, *Akt↓, *COX2↓, *TNF-α↓, *TGF-β1↑, *NO↓, *GSR↑, *NRF2↑, *HO-1↑, *TAC↑, *Inflam↓, *BBB↑, *neuroP↑, *memory↑,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
NA, |
AD, |
NA |
|
|
|
- |
NA, |
Diabetic, |
NA |
|
|
|
- |
NA, |
Stroke, |
NA |
|
|
|
- |
NA, |
LiverDam, |
NA |
|
|
|
- |
NA, |
Park, |
NA |
|
|
|
*mtDam↓, *BioAv↝, *BioAv↑, *OS↑, *eff↑, *eff↑, *cognitive↑, *DNAdam↓, *SIRT1↑, *cardioP↑, *ROS↓, *Dose↝, *BioAv↑, *hepatoP↑, *eff↑, *BG↓, *creat↓,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*ROS↓, *Inflam↓, TumCG↓, *neuroP↑, *cardioP↑, *LDL↓, *BioAv↝, *BioAv↓, *BioAv↑, *SIRT1↑, *mTOR↑, *BDNF↑, *cognitive↑,
Showing Research Papers: 1 to 8 of 8
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
GSTs↑, 1, HO-1↑, 1, NRF2↑, 1,
Proliferation, Differentiation & Cell State ⓘ
TumCG↓, 1,
Immune & Inflammatory Signaling ⓘ
IL1β↓, 1, Inflam↓, 1, NF-kB↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↝, 1, ChemoSen↑, 1,
Functional Outcomes ⓘ
cardioP↑, 1, cognitive↑, 2,
Total Targets: 11
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 5, Catalase↑, 2, GPx↑, 2, GSH↑, 3, GSR↑, 1, GSTs↓, 1, H2O2↓, 1, HO-1↑, 2, lipid-P↓, 1, MDA↓, 1, MPO↓, 2, NRF2↑, 3, ROS?, 1, ROS↓, 8, SOD↑, 6, TAC↑, 1, VitC↑, 1, VitE↑, 1,
Mitochondria & Bioenergetics ⓘ
ATP↑, 1, MMP↑, 1, mtDam↓, 1,
Core Metabolism/Glycolysis ⓘ
12LOX↓, 2, CREB↑, 1, LDL↓, 2, PPARα↑, 1, PPARγ↑, 1, SIRT1↑, 2,
Cell Death ⓘ
Akt↓, 1, Bax:Bcl2↓, 1, Casp3↓, 1, Casp9↑, 1, iNOS↓, 1, MAPK↓, 1,
Kinase & Signal Transduction ⓘ
TRPV3↑, 1,
Transcription & Epigenetics ⓘ
other↓, 1,
Protein Folding & ER Stress ⓘ
GRP78/BiP↑, 1, UPR↑, 1,
DNA Damage & Repair ⓘ
DNAdam↓, 1,
Proliferation, Differentiation & Cell State ⓘ
GSK‐3β↓, 2, mTOR↑, 1, STAT3↓, 1,
Migration ⓘ
MMP2↓, 1, MMP9↓, 1, TGF-β1↑, 1,
Angiogenesis & Vasculature ⓘ
NO↓, 2, NO↑, 1,
Barriers & Transport ⓘ
BBB↑, 6,
Immune & Inflammatory Signaling ⓘ
COX2↓, 5, IL10↑, 2, IL1β↓, 4, IL33↓, 1, IL6↓, 4, IL6↑, 1, IL8↓, 1, Inflam↓, 6, NF-kB↓, 4, PGE2↓, 1, TLR4↓, 1, TNF-α↓, 5,
Synaptic & Neurotransmission ⓘ
AChE↓, 1, BDNF↑, 4, tau↓, 1, TrkB↑, 1,
Protein Aggregation ⓘ
Aβ↓, 2, BACE↓, 1, NLRP3↓, 1, β-Amyloid↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 2, BioAv↑, 6, BioAv↝, 8, Dose↝, 2, eff↑, 7, Half-Life↑, 1, Half-Life↝, 1,
Clinical Biomarkers ⓘ
BG↓, 1, BloodF↑, 1, creat↓, 1, GutMicro↑, 1, IL6↓, 4, IL6↑, 1,
Functional Outcomes ⓘ
cardioP↑, 3, cognitive↑, 4, hepatoP↑, 2, memory↑, 3, motorD↑, 1, neuroP↑, 8, OS↑, 1, toxicity↓, 1, toxicity↑, 1,
Total Targets: 89
Scientific Paper Hit Count for: BioAv, bioavailability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:75 Cells:% prod#:% Target#:792 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid
Home Page